The runway to a product launch is a herculean effort – multiple teams and workstreams are involved to pave the way with key stakeholders (prescribers, payers, investors, thought leaders, patients and caregivers). The work begins years in advance and, most often, communications is the first out of the gate.
From FDA approval and product launch to post-launch data releases and market changes, communications continues to be at the core of every stage of a product’s life cycle.
Our team is full of experts that understand how each of these phases must be managed but also, more importantly, tied together into a long-term, cohesive plan that supports a company’s goals.
Below, we’ve pulled together a roundup of articles that provide key insights whether you’re prepping for FDA approval, gearing up for market entry or strategizing for future momentum:
- Data Storytelling: Effectively Communicating Clinical Data
- Communicating Along The Regulatory Runway
- Prepping The Market For Launch
- Tips For Maximizing Medical Conferences
- Here To Stay: Turning Launch Milestones Into Momentum
Partnering with a communications firm that is seasoned in the therapeutic space, adept at navigating regulatory hurdles, and skilled at matching strategies to business needs is important not just for launch, but also for opportunities before and after the big moment. Read more in our Rx for Success: Pharma Launch Marketing Guide e-book, created by our experienced team at Padilla.
For more insights on communication and brand strategy, industry trends and more, subscribe today to the Weekly Buzz here.